Oruka Therapeutics, Inc. (ORKA) ownership: Entities affiliated with Fairmount Funds Management LLC 38% · institutions 121% · index and ETF funds 5% (13F 2026-06-30). Insider activity, 90 days: 41 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| FMR (Fidelity) | 9057645.00 | $862.02M | 13.7% | 2026-06-30 |
| BlackRock | 4990181.00 | $474.92M | 7.5% | 2026-06-30 |
| Venrock Adviser, LLC | 4148428.00 | $394.81M | 6.3% | 2026-06-30 |
| Fairmount Funds Management LLC | 3705262.00 | $352.63M | 5.6% | 2026-06-30 |
| Capital Group | 3401639.00 | $323.73M | 5.1% | 2026-06-30 |
| Vanguard | 3366890.00 | $320.43M | 5.1% | 2026-06-30 |
| RTW Investments, LP | 3139030.00 | $298.74M | 4.7% | 2026-06-30 |
| State Street | 2673090.00 | $254.38M | 4.0% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 | |
| Sell | null | 2026-09-01 |
Back to ORKA overview · ORKA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.